Company intelligence / Profile preview
广州市东源药业科技有限公司
- Ownership
- Private
- Development stage
- Other
Overview
Guangzhou Dongyuan Pharmaceutical Technology Co., Ltd. is a specialized life sciences firm headquartered in the Guangzhou Science City, China. The company focuses on the research, development, and technical service of pharmaceutical products, medical devices, and biotechnology applications. Its business model integrates R&D with the wholesale distribution of medical equipment and health-related technologies, catering to both domestic and regional markets. Dongyuan is primarily involved in the development of innovative formulations and the commercialization of Class I and Class II medical devices. By leveraging its location in a high-tech industrial cluster, the company provides technical consulting and technology transfer services to broader pharmaceutical partners.
- Therapeutic areas
- Other
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on 广州市东源药业科技有限公司.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 广州市东源药业科技有限公司.